Drug application
TPN ELECTROLYTES IN PLASTIC CONTAINER (CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE and 2 more)
Drugs@FDA NDA 018895 · HOSPIRA
Key facts
| Drug name | TPN ELECTROLYTES IN PLASTIC CONTAINER |
|---|---|
| Active ingredients | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE, SODIUM CHLORIDE |
| Application type | NDA |
| Application number | 018895 |
| Company | HOSPIRA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 16.5MG/ML;25.4MG/ML;74.6MG/ML;121MG/ML;16.1MG/ML |
| Marketing status | Prescription |
| Reference listed drug | Yes |
| Latest submission class | Type 5 - New Formulation or New Manufacturer |
| Latest submission status date | Jul 20, 1984 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: